To find out more about the meeting, click on the video below to listen to SmartTRAK’s interview with Dr. Sitzman, recorded via Skype from his office in Hattiesburg, Mississippi (11:53 minutes).
Matt Thomas, General Manager and Vice President of Medtronic’s STIM & Early Intervention business discusses the Company’s growth strategies, plans for innovation, and what’s next in spinal cord stimulation in a podcast interview with SmartTRAK at the American Society of Interventional Pain Physicians (ASIPP) 2018 held March 15-17, 2018 in Orlando, FL
Click the Podcast Link to hear the interview, recorded live at ASIPP 2018. (18:55 minutes.)
To receive a downloadable transcript, click the button below...
Cerapedics’ CEO Glen Kashuba and President and COO Jeff Marx, Ph.D. discuss the future of the bone graft substitutes and the uniqueness of i‑FACTOR Peptide Enhanced Bone Graft, a small peptide technology in an interview with Kim French, Sr. Analyst, SmartTRAK Orthbio.
A transcript of SmartTRAK's interview with Glen Kashuba and Jeff Marx is below, or click on the following video to listen to the interview.
Interest in the $2.5B market for pediatric orthopedics has been growing as companies like Wishbone Medical develop an increasing number of anatomically appropriate implants for kids in indications ranging from spinal deformities to hip replacements. Lisa Mahan, VP Content Development, Orthopedics at SmartTRAK recently interviewed Nick Deeter, Founder, Chairman of the Board, and CEO of WishBone Medical, who has been a pioneer in this market segment.
Topics: SmartTRAK Interviews
In the market for stroke devices, Europe seems to be the proving ground for next generation devices, and several companies with novel technologies are emerging from Europe that could potentially reach the US market in the next several years. One European company taking aim at the US market is Bochum, Germany-based phenox GmbH.
Scott Drees, CEO of Nuvectra Corporation, discusses the Company’s challenges and opportunities in 2017, strategies for driving growth and market penetration in neuromodulation, and the Company’s key priorities for 2018 in an interview with SmartTRAK at the North American Neuromodulation Society Annual Meeting held Jan. 11-14, 2018 in Las Vegas, NV.
A transcript of SmartTRAK’s interview with Scott Drees is below, or click the following video to view the interview recorded live at NANS 2018. (17:41 minutes.)
Kas Amirdelfan, MD talked with SmartTRAK at the ASRA 2017 Annual Meeting regarding preliminary 12 month results from the SENZA-ULN study
Kas Amirdelfan, MD, principle investigator of the SENZA-Upper Limb and Neck (ULN) study, spoke with SmartTRAK's Anne Staylor at the recent American Society of Regional Anesthesia and Pain Medicine (ASRA) annual meeting in Lake Buena Vista, FL regarding preliminary 12 month results from SENZA-ULN, the unmet clinical need for chronic intractable ULN pain, factors affecting physician adoption for this indication and what’s next for this research. (See ASRA Poster 4194.)
A transcript of SmartTRAK’s interview with Dr. Amirdelfan is below or click on the following video to view the interview recorded live at ASRA 2017. (13:23 minutes.)
Society of NeuroInterventional Surgery (SNIS) President Donald F. Frei, MD talked with SmartTRAK at the SNIS 14th Annual Meeting regarding the future of neurointerventional surgery.
Don Frei, MD, President of the Society of NeuroInterventional Surgery (SNIS), discusses key studies, trends, and technologies affecting the market for mechanical thrombectomy devices in an interview with SmartTRAK at the SNIS 14th Annual Meeting July 24-27, 2017 in Colorado Springs, CO.
A transcript of SmartTRAK’s interview with Don Frei, MD, is below. To listen to the audio interview recorded live at SNIS 2017, click here .
Reducing the recurrence of diabetic foot ulcers (DFU) or increasing ulcer free days is critical for patients with diabetes, as recurrence rates are 40% at one year, 66% at three years, and 75% at five years. At the DF Con meeting in Houston in March, BioMedGPS interviewed David G. Armstrong, DMP, MD, PhD, regarding his research on the use of fat grafting as a means to reduce recurrence of DFUs. Today, fat grafting is being rapidly adopted in plastic and reconstructive surgery, but is now being explored for care of the diabetic foot.